CND261

· Candid Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CND261, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label Study of CND261 in Seropositive Rheumatoid Arthritis [Phase 1]